Vyome Biosciences has appointed Dr. Bhaskar Chaudhuri, Ph.D. and Alan Rosling to its Board of Directors.
, a clinical stage dermatology based innovative biopharmaceutical company, which is pioneering the development of next generation antibiotics and antifungal agents that target antimicrobial resistance for opportunist pathogens of the skin, announced today the
“As Vyome scales up multiple drug development programs, enters clinical trials and accelerates the commercialization phase, Dr. Chaudhuri will add tremendous strategic experience to the Board. His vast experience in commercializing novel dermatology drugs, and leadership with top-tier pharmaceutical companies will brings significant value to Vyome”, said Venkateswarlu Nelabhotla, Co-founder & CEO of Vyome Biosciences.
“Vyome is a proving to be a highly credible innovative player in the life sciences industry, with novel platforms and drug development programs, and I am delighted to be a part of the Company’s illustrious Board of Directors. Vyome’s current portfolio of innovative and breakthrough products provides a strong foundation for the company to emerge as a global leader in its field,” Dr. Chaudhuri added.
Dr. Bhaskar Chaudhuri has more than 25 years of experience with leading biopharmaceutical companies in leadership, strategy and management, drug research & development, and commercialization in the US, EU and emerging markets. He has led the development and FDA approval of multiple New Drug Applications (NDAs).
Rosling brings strong global business experience to the Board, and he will be a tremendous resource for the company as it continues to go from strength to strength in the coming years,” commented Dr. Raghunath Mashelkar, the Chairman of Vyome’s Board of Directors.
Vyome Biosciences is a clinical stage dermatology-based biopharmaceutical company, which has novel platforms technologies and a deep pipeline of novel drugs for antibiotic resistant Acne, other opportunistic pathogens and antifungal agents. fii-news.com
Projects: Tremendous time to be in Indian RE space, says Harish Shah
Azure will grow rapidly in India's renewable energy sector, says Rosling Azure Power (NYSE: AZRE) has appointed Harsh Shah as...
